The SphK/S1P/S1PR pathway was previously discussed as an important player in viral infection and inflammation, and many data strongly support that modulating the components of SphK/S1P/S1PR provides beneficial assistance in the management of COVID‐19 disease (reviewed in Refs. This evidence concerns the gene SPHK1 and viral infectious disease.